Showing results (151-160 of 173) with videos related to
Sort By:
Pageof 18
The Journal of Rheumatology|April 13, 2002
Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosusHitoaki Okazaki, Daisuke Hirata, Takeshi Kamimura, et al.Journal of Biochemistry|December 25, 2008
Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ miceXiaoming Yang, Patricia A Wood, Christine M Ansell, et al.British Journal of Clinical Pharmacology|August 22, 2009
Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjectsKentarou Ushijima, Shu-ichi Tsuruoka, Hidetoshi Tsuda, et al.Clinical Pharmacology and Therapeutics|March 17, 2025
Night-Time Chronotherapy with Methylprednisolone Prevents an Acute Rejection in Pediatric Patients with Liver Transplantation: A Randomized Clinical TrialKentaro Ushijima, Yukihiro Sanada, Shinya Otomo, et al.Clinical and Experimental Pharmacology & Physiology|January 18, 2013
Dosing time-dependent effect of raloxifene on plasma plasminogen activator inhibitor-1 concentrations in post-menopausal women with osteoporosisHitoshi Ando, Toshiki Otoda, Hitoshi Ookami, et al.Clinical and Experimental Pharmacology & Physiology|May 31, 2012
Pharmacokinetics and pharmacodynamics of insulin aspart in patients with type 2 diabetes: assessment using a meal tolerance test under clinical conditionsHitoshi Ando, Seiichiro Kurita, Akiko Shimizu, et al.Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Claudin-2-deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubulesShigeaki Muto, Masaki Hata, Junichi Taniguchi, et al.Biochemical and Biophysical Research Communications|March 17, 2009
The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitisHitoshi Ando, Toshinari Takamura, Naoto Matsuzawa-Nagata, et al.Cancer Chemotherapy and Pharmacology|October 29, 2018
Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphismsAkimitsu Maeda, Kei Irie, Hitoshi Ando, et al.Cancer Chemotherapy and Pharmacology|April 12, 2015
Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injuryKazuhiko Nakano, Hitoshi Ando, Shinsuke Kurokawa, et al.Pageof 18